Sales rise 42.02% to Rs 2223.77 crore
Net profit of Jubilant Life Sciences rose 2.26% to Rs 152.40 crore in the quarter ended March 2018 as against Rs 149.03 crore during the previous quarter ended March 2017. Sales rose 42.02% to Rs 2223.77 crore in the quarter ended March 2018 as against Rs 1565.79 crore during the previous quarter ended March 2017.For the full year,net profit rose 10.41% to Rs 634.42 crore in the year ended March 2018 as against Rs 574.62 crore during the previous year ended March 2017. Sales rose 28.78% to Rs 7424.78 crore in the year ended March 2018 as against Rs 5765.27 crore during the previous year ended March 2017.
ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales2223.771565.79 42 7424.785765.27 29 OPM %20.5919.48 -20.4523.33 - PBDT408.30235.32 74 1274.131029.04 24 PBT226.56160.10 42 859.08737.64 16 NP152.40149.03 2 634.42574.62 10
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
